Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo
Kelly M. Lohr, Alison I. Bernstein, Kristen A. Stout, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 27, pp. 9977-9982
Open Access | Times Cited: 184

Showing 51-75 of 184 citing articles:

Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo
Laura M. Vecchio, Patricia Sullivan, Amy R. Dunn, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 4, pp. 960-979
Open Access | Times Cited: 31
The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
David S. Goldstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5999-5999
Open Access | Times Cited: 28
Developmental pyrethroid exposure causes a neurodevelopmental disorder phenotype in mice
Melissa A. Curtis, Rohan K. Dhamsania, Rachel C. Branco, et al.
PNAS Nexus (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 11
Developmental exposure to the Parkinson’s disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice
S. Boyd, Nathan C. Kuhn, Joseph R. Patterson, et al.
Toxicological Sciences (2023) Vol. 196, Iss. 1, pp. 99-111
Open Access | Times Cited: 11
HDAC4/5 Inhibitor, LMK‐235 Improves Animal Voluntary Movement in MPTP‐Induced Parkinson's Disease Model
Heejin Lee, Hyun‐Jin Kim, Ju‐Sik Min, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 1
Open Access
Identifying potential genes driving ferroptosis in the substantia nigra and dopaminergic neurons in Parkinson's disease
Arunaloke Chakrabarti, Sonia Verma
Molecular and Cellular Neuroscience (2025) Vol. 132, pp. 103993-103993
Closed Access
3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine
Yunden Jinsmaa, Yehonatan Sharabi, Patti Sullivan, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 366, Iss. 1, pp. 113-124
Open Access | Times Cited: 37
Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice
Kristen A. Stout, Amy R. Dunn, Kelly M. Lohr, et al.
ACS Chemical Neuroscience (2016) Vol. 7, Iss. 10, pp. 1364-1373
Open Access | Times Cited: 33
Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain
Rachel A. Cliburn, Amy R. Dunn, Kristen A. Stout, et al.
Journal of Chemical Neuroanatomy (2016) Vol. 83-84, pp. 82-90
Open Access | Times Cited: 32
Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease
Fanni F. Geibl, Martin T. Henrich, Wolfgang H. Oertel
Journal of Neural Transmission (2019) Vol. 126, Iss. 4, pp. 377-396
Closed Access | Times Cited: 30
Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens
Daniel F. Manvich, Alyssa K. Petko, Rachel C. Branco, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 8, pp. 1445-1455
Open Access | Times Cited: 30
Venlafaxine plus melatonin ameliorate reserpine-induced depression-like behavior in zebrafish
Yaqiu Tang, Zhuoran Li, Shao-Zhi Zhang, et al.
Neurotoxicology and Teratology (2019) Vol. 76, pp. 106835-106835
Closed Access | Times Cited: 30
Role of Protein Damage Inflicted by Dopamine Metabolites in Parkinson’s Disease: Evidence, Tools, and Outlook
Alexander K. Hurben, Natalia Tretyakova
Chemical Research in Toxicology (2022) Vol. 35, Iss. 10, pp. 1789-1804
Open Access | Times Cited: 16
Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone
Svein I. Støve, Åge A. Skjevik, Knut Teigen, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 16
(+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson’s Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis
Lina Ding, Long Wang, Jiaxin Yang, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 11, pp. 2308-2321
Closed Access | Times Cited: 3
Gastrodin relieves Parkinson's disease-related motor deficits by facilitating the MEK-dependent VMAT2 to maintain dopamine homeostasis
Meihuan Zhao, Yongtao Zhou, Ruilin Sheng, et al.
Phytomedicine (2024) Vol. 132, pp. 155819-155819
Closed Access | Times Cited: 3
The relationship between the dopaminergic system and depressive symptoms in cervical dystonia
Evelien Zoons, Marina A.J. Tijssen, Yasmine E. M. Dreissen, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2017) Vol. 44, Iss. 8, pp. 1375-1382
Open Access | Times Cited: 32
Detection of Free and Protein-Bound ortho-Quinones by Near-Infrared Fluorescence
Joseph R. Mazzulli, Lena F. Burbulla, Dimitri Krainc, et al.
Analytical Chemistry (2016) Vol. 88, Iss. 4, pp. 2399-2405
Open Access | Times Cited: 31
Photoactivation of ERK/CREB/VMAT2 pathway attenuates MPP + -induced neuronal injury in a cellular model of Parkinson's disease
Xiaotong Gu, Lei Liu, Qi Shen, et al.
Cellular Signalling (2017) Vol. 37, pp. 103-114
Closed Access | Times Cited: 29
RTP801 is a critical factor in the neurodegeneration process of A53T α‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress
Zhao Zhang, Shifeng Chu, Shasha Wang, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 4, pp. 590-605
Open Access | Times Cited: 29
Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway
Kyoko Mashima, Shinichi Takahashi, Kazushi Minami, et al.
ASN NEURO (2018) Vol. 10, pp. 175909141877556-175909141877556
Open Access | Times Cited: 29
Combined exposure to methylmercury and manganese during L1 larval stage causes motor dysfunction, cholinergic and monoaminergic up-regulation and oxidative stress in L4 Caenorhabditis elegans
Maria Rosa Chitolina Schetinger, Tanara V. Peres, Letícia Priscilla Arantes, et al.
Toxicology (2018) Vol. 411, pp. 154-162
Open Access | Times Cited: 29
Mechanism for antiParkinsonian effect of resveratrol: Involvement of transporters, synaptic proteins, dendrite arborization, biochemical alterations, ER stress and apoptosis
Ashish Singh, Arun Kumar Yadawa, Swati Chaturvedi, et al.
Food and Chemical Toxicology (2021) Vol. 155, pp. 112433-112433
Closed Access | Times Cited: 23
A model of dopamine and serotonin-kynurenine metabolism in cortisolemia: Implications for depression
Felipe Dalvi-Garcia, Luís L. Fonseca, Ana Tereza Ribeiro de Vasconcelos, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 5, pp. e1008956-e1008956
Open Access | Times Cited: 21
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1204-1268
Open Access | Times Cited: 21

Scroll to top